Nexgel Inc
NASDAQ:NXGL

Watchlist Manager
Nexgel Inc Logo
Nexgel Inc
NASDAQ:NXGL
Watchlist
Price: 0.6819 USD -4.87% Market Closed
Market Cap: $5.6m

Relative Value

NXGL doesn't have a meaningful market cap.

The Relative Value of one NXGL stock under the Base Case scenario is 3.4355 USD. Compared to the current market price of 0.6819 USD, Nexgel Inc is Undervalued by 80%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NXGL Relative Value
Base Case
3.4355 USD
Undervaluation 80%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

NXGL Competitors Multiples
Nexgel Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Nexgel Inc
NASDAQ:NXGL
5.6m USD 0.5 -1.9 -2.1 -1.8
JP
Hoya Corp
TSE:7741
9.5T JPY 10.4 38.1 27.6 33.1
US
Medline Inc
NASDAQ:MDLN
55.2B USD 0 0 0 0
CH
Alcon AG
SIX:ALC
28.4B CHF 3.5 37.3 14.4 27.9
DK
Coloplast A/S
CSE:COLO B
94.8B DKK 3.5 24.6 13 15.5
US
Align Technology Inc
NASDAQ:ALGN
12.8B USD 3.2 31.2 13.4 18.5
UK
ConvaTec Group PLC
LSE:CTEC
4.3B GBP 2.4 33.1 11.6 18.1
CA
Bausch + Lomb Corp
NYSE:BLCO
5.6B USD 1.1 -15.4 16.8 54.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
39.3B CNY 8.6 23.8 21.4 21.4
JP
Asahi Intecc Co Ltd
TSE:7747
870.8B JPY 6.7 49.2 23.3 31.6
CN
Intco Medical Technology Co Ltd
SZSE:300677
37.3B CNY 3.8 21.9 32.5 32.5
P/E Multiple
Earnings Growth PEG
US
Nexgel Inc
NASDAQ:NXGL
Average P/E: 32.4
Negative Multiple: -1.9
N/A N/A
JP
Hoya Corp
TSE:7741
38.1
14%
2.7
US
M
Medline Inc
NASDAQ:MDLN
Not Available
29%
N/A
CH
Alcon AG
SIX:ALC
37.3
32%
1.2
DK
Coloplast A/S
CSE:COLO B
24.6
21%
1.2
US
Align Technology Inc
NASDAQ:ALGN
31.2
34%
0.9
UK
ConvaTec Group PLC
LSE:CTEC
33.1
41%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -15.4 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.8
9%
2.6
JP
A
Asahi Intecc Co Ltd
TSE:7747
49.2
38%
1.3
CN
Intco Medical Technology Co Ltd
SZSE:300677
21.9
12%
1.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Nexgel Inc
NASDAQ:NXGL
Average EV/EBITDA: 19.3
Negative Multiple: -2.1
N/A N/A
JP
Hoya Corp
TSE:7741
27.6
12%
2.3
US
M
Medline Inc
NASDAQ:MDLN
Not Available
9%
N/A
CH
Alcon AG
SIX:ALC
14.4
9%
1.6
DK
Coloplast A/S
CSE:COLO B
13
6%
2.2
US
Align Technology Inc
NASDAQ:ALGN
13.4
14%
1
UK
ConvaTec Group PLC
LSE:CTEC
11.6
11%
1.1
CA
Bausch + Lomb Corp
NYSE:BLCO
16.8
29%
0.6
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
21.4
13%
1.6
JP
A
Asahi Intecc Co Ltd
TSE:7747
23.3
12%
1.9
CN
Intco Medical Technology Co Ltd
SZSE:300677
32.5
51%
0.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Nexgel Inc
NASDAQ:NXGL
Average EV/EBIT: 28.1
Negative Multiple: -1.8
N/A N/A
JP
Hoya Corp
TSE:7741
33.1
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available
18%
N/A
CH
Alcon AG
SIX:ALC
27.9
26%
1.1
DK
Coloplast A/S
CSE:COLO B
15.5
7%
2.2
US
Align Technology Inc
NASDAQ:ALGN
18.5
21%
0.9
UK
ConvaTec Group PLC
LSE:CTEC
18.1
21%
0.9
CA
Bausch + Lomb Corp
NYSE:BLCO
54.3
72%
0.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
21.4
10%
2.1
JP
A
Asahi Intecc Co Ltd
TSE:7747
31.6
N/A N/A
CN
Intco Medical Technology Co Ltd
SZSE:300677
32.5
24%
1.4
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett